FUTURE试验:三种MRI靶向前列腺穿刺活检技术的不良事件比较
FUTURE试验事后分析纳入234例既往系统穿刺阴性且MRI发现PIRADS≥3病灶的男性,随机1:1:1接受MRI-TB、FUS-TB或COG-TB。轻微不良事件发生率分别为53%、71%、85%(p<0.001),穿刺针数增加与不良事件风险升高相关(OR 1.11,95%CI 1.06-1.17,p<0.001)。经直肠途径增加任何不良事件风险(OR 2.54,95%CI 1.16-5.77,p<0.05)。穿刺未影响IPSS(Δ0.3,p=0.1)和IIEF-5(Δ-0.4,p=0.5)。
要点
- 三种MRI靶向穿刺技术轻微不良事件发生率差异显著,MRI-TB最低(53%)。
- 每增加1针穿刺,不良事件总体风险升高(OR 1.11,95%CI 1.06-1.17)。
- 经直肠途径较经会阴途径增加任何不良事件风险(OR 2.54,95%CI 1.16-5.77)。
核心结论
- 三种MRI靶向穿刺技术间轻微不良事件发生率存在显著差异,MRI-TB最低。
- 穿刺针数增加与不良事件总体风险升高独立相关。
- 经直肠途径增加任何不良事件风险,但尿路感染风险增加无统计学意义。
- 前列腺穿刺对患者自报的排尿和勃起功能无显著影响。
研究设计与样本
- 多中心随机对照试验(FUTURE试验)的事后分析,共纳入234例既往系统穿刺阴性且疑似前列腺癌的男性。
- 3-T多参数MRI显示PIRADS≥3病灶,患者按1:1:1随机分至MRI-TB、FUS-TB或COG-TB组。
- 不良事件采用Clavien-Dindo分级,组间比较用Pearson卡方检验。
- 采用单因素logistic回归分析穿刺针数、穿刺途径和抗凝药物使用对不良事件的影响。
- 患者基线和穿刺后30天填写IPSS和IIEF-5问卷,差值采用单因素方差分析比较。
主要发现
- 轻微不良事件发生率:MRI-TB组53%,FUS-TB组71%,COG-TB组85%(p<0.001)。
- 穿刺针数每增加1针,不良事件风险OR为1.11(95%CI 1.06-1.17,p<0.001)。
- 使用抗凝药物与出血并发症无显著关联(OR 1.24,95%CI 0.66-2.35,p=0.5)。
- 经直肠途径(MRI-TB+COG-TB)增加任何不良事件风险(OR 2.54,95%CI 1.16-5.77,p<0.05)。
- 经直肠途径对尿路感染风险的影响无统计学意义(OR 3.69,95%CI 0.46-168.4,p=0.3)。
临床怎么用
- 临床选择MRI靶向穿刺技术时,应权衡轻微不良事件风险,MRI-TB可能并发症更少。
- 减少穿刺针数可能降低不良事件总体风险。
- 经直肠途径穿刺需警惕任何不良事件风险升高。
- 穿刺对排尿和勃起功能的短期影响较小,可用于患者咨询。
局限性
- FUS-TB和COG-TB组额外进行了系统穿刺,而MRI-TB组省略了系统穿刺,导致组间比较困难。
- 本研究为事后分析,可能存在未控制的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Three techniques of magnetic resonance imaging (MRI)-based targeted biopsy (TB) of the prostate exist. There is no superiority regarding diagnostic efficacy of prostate cancer (PCa) detection. OBJECTIVE: To compare adverse events (AEs) among three TB techniques and to evaluate the effect on urinary and erectile function. DESIGN, SETTING, AND PARTICIPANTS: Post hoc analysis of a multicentre randomised controlled trial among men with negative systematic biopsy (SB) and suspicion of PCa. INTERVENTION: In 234 patients, 3-T multiparametric MRI demonstrated PIRADS≥ 3 lesions, and patients were randomised 1:1:1 for TB: transrectal in-bore MRI TB (MRI-TB), transperineal MRI-transrectal ultrasound (TRUS) fusion TB (FUS-TB), and transrectal cognitive TRUS TB (COG-TB). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: AEs (Clavien-Dindo) were compared using Pearson chi-square test. Univariate logistic regression tests were performed for the number of cores, biopsy approach, and usage of anticoagulants. The participants filled in baseline and 30-d postbiopsy International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF-5) questionnaires. The delta between measurements was compared using one-way analysis of variance. RESULTS AND LIMITATIONS: There were significant differences in minor AEs: 53% in MRI-TB, 71% in FUS-TB, and 85% in COG-TB (p < 0.001). The number of cores was associated with AEs (odds ratio [OR] 1.11 per extra biopsy [95% confidence interval {CI} 1.06-1.17, p < 0.001]). Anticoagulants were not associated with bleeding complications (OR 1.24 [95% CI 0.66-2.35, p = 0.5]). Transrectal approach (MRI-TB + COG-TB) increased the risk of any AE (OR 2.54 [95% CI 1.16-5.77, p < 0.05]) and nonsignificantly increased the risk of urinary tract infections (OR 3.69 [95% CI 0.46-168.4, p = 0.3]). Biopsy did not impact urinary (ΔIPSS 0.3, p = 0.1) and erectile function (ΔIIEF-5 -0.4, p = 0.5). The main limitation was that additional SB was performed in FUS-TB and COG-TB, and was omitted in MRI-TB, making comparison difficult. CONCLUSIONS: There was a significant difference in minor AEs among groups. An increase in the number of cores increased the overall risk of AEs. A low AE occurrence in MRI-TB was likely caused by the omission of SB. Prostate biopsy did not impact self-reported urinary and erectile functions. PATIENT SUMMARY: In this study, we compared the complication rates of three techniques of magnetic resonance imaging (MRI)-based targeted biopsy of the prostate. We found a significant difference in the occurrence of minor complication rates among three groups in favour of transrectal in-bore MRI targeted biopsy, likely caused by the omission of additional systematic biopsy in this group.
引用
- Wegelin O, Exterkate L, van der Leest M, et al. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial. Eur Urol Oncol. 2019. PMID: 31519516. doi:10.1016/j.euo.2019.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。